Agent for treatment of pulmonary disease

Details Agent for treatment of pulmonary disease Agent for treatment of pulmonary disease

A - Human Necessities

61

K

A61K 31/47 (2006.01) A61K 9/51 (2006.01) A61K 9/72 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/505 (2006.01) A61K 45/00 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2685054

Disclosed is a highly effective agent for treatment of pulmonary diseases with little side effects. Specifically disclosed is an agent for treatment of pulmonary diseases by endotracheal administration, which contains a biocompatible polymer nanoparticle containing an HMG-CoA reductase inhibitor.

L'invention concerne un agent hautement efficace pour le traitement de maladies pulmonaires avec peu d'effets secondaires. L'invention concerne spécifiquement un agent pour le traitement de maladies pulmonaires par administration endotrachéale, qui contient des nanoparticules de polymère biocompatible contenant un inhibiteur de la HMG-CoA réductase.

Affiliated with

Also associated with

Rating

Agent for treatment of pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treatment of pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treatment of pulmonary disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1576232